In Devens, Massachusetts, VulcanForms did what serious manufacturing companies do when the moment demands it. They raised $220 million in an oversubscribed Series D and did not bother turning it into...
In Devens, Massachusetts, VulcanForms did what serious manufacturing companies do when the moment demands it. They raised $220 million in an oversubscribed Series D and did not bother turning it into a victory lap. This was capital with intent. Led by Eclipse and 1789 Capital, with Washington Harbour, Fontinalis Partners, IEQ Capital, and other strategic partners in the room, the round pushed total funding to roughly $725 million and quietly reinforced a larger message. The United States is done pretending critical metal production can live offshore without consequence.
VulcanForms was never built as a software deck chasing buzz. Founded in 2015 by Martin C. Feldmann and A. John Hart out of MIT, the company was designed to solve three problems metal additive manufacturing kept dodging: throughput, cost, and material performance. The answer was not prettier printers. It was integration. Proprietary laser powder bed fusion systems, precision CNC machining, automation, and AI-driven software stitched into a single digital thread, running 24/7, under one roof, on American soil.
That roof matters. VulcanOne in Devens spans 160,000 square feet and runs more than two megawatts of laser capacity through VulcanForms’ GEN 3 systems. Newburyport adds over 60 advanced CNC machines and decades of machining discipline through the Arwood acquisition. Add AS9100 certification, micron-level precision, fully dense titanium, nickel, steel, aluminum, copper, and cobalt-chrome parts, and you stop calling this additive manufacturing. You start calling it infrastructure.
The timing is not subtle. VulcanForms is already producing parts across aerospace and defense programs, medical devices, semiconductor and compute infrastructure, consumer products, and industrial equipment. The Series D capital is earmarked to expand capacity, advance materials, and build a third Devens facility that will bring roughly 150 more people into the operation. This is scale with fingerprints, not slogans.
Leadership reflects that shift. Kevin Kassekert, Chief Executive Officer, came in from Tesla and Redwood Materials to turn production into muscle. Jay Martin, President, brings decades of commercial execution from Globus Medical, Intuitive Surgical, and Boston Scientific. Eclipse partner Greg Reichow remains close, because factories do not forgive theory. They only reward repetition.
VulcanForms is not selling machines. They are selling certainty. One supplier, one digital system, one domestic chain of custody from powder to finished part. In a world relearning the cost of fragility, VulcanForms is betting that control beats convenience, and the market seems ready to keep listening.